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A B S T R A C T
Objectives: The individual 2007 Infectious Disease Society of America (IDSA)/American Thoracic Society
(ATS) minor criteria for severe community-acquired pneumonia (CAP) are of unequal weight in
predicting mortality. It is not clear whether the combinations of predictive ﬁndings might imply diverse
severities or different mortalities.
Methods: A prospective two centre cohort study was performed of 385 severe CAP patients fulﬁlling
three or more IDSA/ATS minor criteria amongst 1430 patients.
Results: Hospital mortality rose sharply from 5.7%, 9.9%, and 16.5%, respectively, for patients with none
of three predictive ﬁndings most strongly associated to mortality (PaO2/FiO2  250 mm Hg, confusion
and uraemia), one of those, and two of those to 38.6% for patients with all those (p < 0.001). The number
of three predictive ﬁndings present had a signiﬁcantly increased odds ratio for mortality of 2.796
(p < 0.001), and had the degree of positive association with sequential organ failure assessment scores at
72 hours, incurring signiﬁcantly longer hospital stay and higher costs.
Conclusions: Different combinations of 2007 IDSA/ATS minor criteria for severe CAP were associated to
diverse severities and different mortalities. The combination of PaO2/FiO2  250 mm Hg, confusion and
uraemia predicted more severity and higher mortality compared with others.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Community-acquired pneumonia (CAP) is a common infection.
Despite substantial advances in therapeutic options, the mortality
remains unacceptably high.1,2 It was as high as 58% when severe§ Part of the data (NO. 31) was accepted for Poster Discussion at the ERS
(European Respiratory Society) Barcelona 2013 Annual Congress (7-11 September).
The abstract (NO. 2245395) has been accepted for poster presentation at the CHEST
2015 annual meeting in Montreal, Quebec, Canada (October 24-28); and for
presentation, poster discussion (NO. 2260883), at the 2015 AARC (the American
Association for Respiratory Care) open forum, November 7-10 in Tampa, Florida.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).CAP patients were admitted to the intensive care unit (ICU).3 The
Infectious Disease Society of America (IDSA) and the American
Thoracic Society (ATS) issued guidelines in 2007 which deﬁned
severe CAP—when one of two major criteria (the need for invasive
mechanical ventilation or vasopressors) or three of nine minor
criteria are fulﬁlled. The minor criteria included variables in the
CURB-65 score except age, arterial oxygen pressure/fraction
inspired oxygen (PaO2/FiO2)  250 mm Hg, multilobar inﬁltrates,
leucopenia, thrombocytopenia, and hypothermia. However,
whether each of the minor criteria is of equal weight is not clear.1
Brown et al.4 reported the IDSA/ATS 2007 criterion of confusion
was the most predictive of severe CAP. Liapikou et al.5 found
that each of the minor criteria is of unequal weight in
predicting mortality (mental confusion and leucopenia had the
strongest association with mortality) and could not demonstrate
an association between hypotension, thrombocytopenia andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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 250 mm Hg, confusion and uremia had the strongest association
with mortality, and that leukopenia, hypothermia and hypotension
were not associated with mortality.6 However, Phua et al.7 found
that each minor criterion was predictive of mortality and that the
presence of PaO2/FiO2  250 mm Hg and confusion had the
strongest association with mortality. Chalmers et al.8 found that
each minor criterion was predictive of mortality, but hypotension,
multilobar radiographic shadowing and hypothermia had the
strongest association with mortality. Sibila et al.9 reported that the
combinations of different severity criteria (the 2007 IDSA/ATS
minor criteria and other minor non-IDSA/ATS criteria) were
associated with different prediction for ICU admission.
ICU resources are often scarce in many institutions, and
admission of patients with CAP who would not beneﬁt more from
ICU care is problematic. A major challenge in the management of
CAP is to identify patients at risk for rapidly developing adverse
medical outcomes among those presenting to the emergency
department without the IDSA/ATS major criteria. On the basis of
the above-mentioned studies, different combinations of 2007 IDSA/
ATS minor criteria for severe CAP might be associated to diverse
severities and different mortalities, and the patients fulﬁlling the
combination of three predictive ﬁndings most strongly associated to
mortality, e.g. PaO2/FiO2  250 mm Hg, confusion and uraemia,
might have more severity and higher mortality compared with
others, suggesting that the former might have a higher priority for
treatment in ICU. We therefore conducted this study with the aim of
determining the associations in an adult population with CAP.
2. Patients and methods
2.1. Design and setting
A prospective two centre cohort study of 1430 adult CAP
patients was conducted between 2010 and 2013 at the Depart-
ments of Respiratory Medicine in two Chinese afﬁliated tertiary
hospitals of two medical colleges. The eligible patients were those
fulﬁlling at least three of 2007 IDSA/ATS nine minor criteria for
severe CAP.
2.2. Criteria for enrolment
CAP was deﬁned as an acute infection of the pulmonary
parenchyma associated with an acute inﬁltrate on the chest
radiograph with two or more symptoms including fever (> 38 8C),
rigors, sweats, new cough or change in colour of respiratory
secretions, chest discomfort or dyspnoea.7 The patients with
severe CAP—when at least three of 2007 IDSA/ATS nine minor
criteria are fulﬁlled were recruited. Patients who were < 18 yrs,
who had been hospitalized during the 28 days preceding the study,
who had severe immunosuppression (e.g., patients with neutro-
penia after chemotherapy or bone marrow transplantation,
patients with drug-induced immunosuppression as a result of
solid-organ transplantation or corticosteroid or cytotoxic therapy,
and patients with HIV-related disorders),10 active tuberculosis, or
end-stage diseases, who had a written ‘‘do not resuscitate’’ order,
who had healthcare-associated pneumonia, or who fulﬁlled any
IDSA/ATS major criteria for severe CAP in the emergency
department (i.e., the need for mechanical ventilation or vaso-
pressors) were excluded. Healthcare-associated pneumonia was
deﬁned according to the ATS/IDSA guidelines in 2005.11
2.3. Clinical management
Patients with severe CAP were admitted to a general ward and
cared for by respiratory physicians using the ATS guidelines1,12 andthe Surviving Sepsis Campaign guidelines.13,14 The initial antibiotic
regimens were consistent with the guidelines on the management
of CAP, in addition to subsequently cultured pathogens. Therefore,
all patients received adequate antibiotics and were discharged
when they reached clinical stability and became afebrile.
2.4. Deﬁnition of the three predictive ﬁndings most strongly
associated to mortality
On the basis of the weight of 2007 IDSA/ATS nine minor criteria
for severe CAP4–7 in predicting mortality and our local settings, the
minor criteria with the three highest odds ratios (OR) for mortality
were regarded as the three predictive ﬁndings most strongly
associated to mortality, i.e. PaO2/FiO2  250 mm Hg, confusion,
and uremia.
2.5. Outcomes
The primary outcome was hospital mortality. Secondary
outcomes incorporated SOFA (sequential organ failure assessment)
scores at 72 hours after start of therapy, hospital length of stay
(LOS), and costs. Laboratory variables were measured by the
hospital clinical laboratories.
2.6. Data collection
Clinical and diagnostic data, and radiological features were
collected. SOFA scores at 72 hours after commencing therapy were
calculated. Costs of dealing with CAP itself were included,
incorporating pharmacy, radiology and laboratory costs, examina-
tion costs, medical staff fees, bed or room fees, and other costs such
as nebulization and oxygen therapy. Costs (also incorporating
relevant pharmacy, radiology and laboratory costs, examination
costs, medical staff fees, and bed or room fees) of dealing with
multiple co-morbidities were excluded. All the patients had chest
radiographys and CT scans. The frontal and lateral chest
radiographic ﬁndings, and CT scan images were classiﬁed
independently by two senior radiologists (LH Liang and QZ Zhao).
The statistician was blinded to the study.
2.7. Statistical analysis
All statistical analyses were performed with Statistical Package
for the Social Science for Windows version 16.0 (SPSS, Chicago, IL,
USA). Categorical variables and continuous variables were
reported as the percentages and the mean  standard deviation
(SD), respectively. Chi-Square test, one-way analysis of variance,
univariate logistic regression, and Spearman rank correlation were
employed. A p value of < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Baseline characteristics of the patients
1430 consecutive CAP patients were assessed and 21 cases were
excluded from this investigation due to exclusion criteria.
1024 CAP patients with less than three of the IDSA/ATS nine
minor criteria were further excluded according the design.
Therefore, 385 severe CAP patients were enrolled. Baseline
characteristics of the patients were shown in Table 1. The average
ages were 62.3  13.0 yrs. The percentage of male sex was
39.5. Sputum was cultured from all patients, but the etiologies were
detected in only 21.8% of the patients. Hence, the data were not
shown. 44 patients simultaneously fulﬁlled the three predictive
ﬁndings (PaO2/FiO2  250 mm Hg, confusion, and uraemia),
Fig. 1. Study Flow Chart.
Table 1










PaO2/FiO2  250 mm Hg 43.7 (167) 9.808 (5.571-17.266) < 0.001
Confusion 21.8 (84) 7.289 (3.884-13.677) < 0.001
Uremia 41.3 (159) 13.400 (7.334-24.485) < 0.001
Respiratory
rate  30 breaths/min
35.1 (135) 2.540 (1.306-4.941) 0.006
Multilobar inﬁltrates 92.5 (357) 2.314 (1.330-4.026) 0.003
Thrombocytopenia 19.2 (74) 2.483 (1.351-4.617) 0.004
Leukopenia 18.2 (70) 0 (0) 0.996
Hypothermia 9.9 (38) 0 (0) 0.997
Hypotension 45.7 (176) 1.719 (0.346-4.953) 0.162
NOTE: OR: Odds ratio. CI: Conﬁdence interval. PaO2/FiO2: Arterial oxygen pressure/
fraction inspired oxygen.
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141 patients with none of those (Fig. 1).
3.2. Hospital mortality according to the combinations of minor
criteria
Associations between predictive ﬁndings and hospital mortali-
ty in the population of 1409 CAP patients were presented in
Table 1. Uremia, PaO2/FiO2  250 mm Hg, and confusion were the
three predictive ﬁndings most strongly associated to mortality.
The overall hospital mortality in the patients with severe CAP
was 13.0%. Mortality increased signiﬁcantly with the number of
three predictive ﬁndings present. It rose sharply from 5.7%, 9.9%,
and 16.5%, respectively, for patients with absence of the three
predictive ﬁndings, one of those, and two of those to 38.6% for
patients with all those(x2 = 45.429, p < 0.001. Table 2). The number
of three predictive ﬁndings present had a signiﬁcant increased OR
for mortality of 2.796 (95% conﬁdence interval, 1.993-3.922;
p < 0.001).
3.3. SOFA scores according to the combinations of minor criteria
SOFA scores increased signiﬁcantly with the number of three
predictive ﬁndings present at 72 hours after commencing therapy
(Table 2). The number of three predictive ﬁndings present had the
degree of positive association with SOFA scores [Rank correlation
coefﬁcient (rs), p; 0.428, < 0.001].
3.4. Hospital LOS and costs according to the combinations of minor
criteria
The differences in hospital LOS and costs between the patients
with different combinations of the minor criteria were shown
in Table 2. The number of three predictive ﬁndings present had
the degree of positive association with hospital LOS and costs
(rs, p; 0.319, < 0.001; 0.375, < 0.001; respectively).Table 2







Mortality (%) 38.6 16.5 
SOFA score 6.09  1.46 4.06  1.56 
Hospital LOS (days) 18.1  5.2 15.8  4.7 
Costs ($) 3212.8  425.8 2384.6  317.3 
NOTE: SOFA: Sequential organ failure assessment. LOS: Length of stay.4. Discussion
Our ﬁndings show that different combinations of 2007 IDSA/
ATS minor criteria for severe CAP were associated to diverse
severities and different mortalities, and that the presence of PaO2/
FiO2  250 mm Hg, confusion and uremia predicted higher SOFA
scores and mortality compared with other combinations.
There are few data that different combinations of 2007 IDSA/
ATS minor criteria for severe CAP might be associated to diverse
severities and different mortalities in the NCBI database. On the
basis of the ﬁndings reported by us,6 Brown et al.,4 Liapikou et al.,5
and Phua et al.,7 PaO2/FiO2  250 mm Hg, confusion, and uremia
had the strongest association with mortality. The minor criteria
might produce cumulative predictive values should several of
them present in a patient. It was not clear whether the
simultaneous presentation of PaO2/FiO2  250 mm Hg, confusion,
and uremia, which were individually strongest predictive, could
produce more value for predicting mortality. This association was
validated in the current study, but Chalmers’ discoveries8 were
different from the ﬁndings reported by us,6 Brown et al.,4 Liapikou
et al.,5 and Phua et al.7 with special regard to the three predictive
ﬁndings of 2007 IDSA/ATS nine minor criteria most strongly
associated to mortality. It is known that clinical prediction rules
should be recalibrated to local settings.15 Therefore, future
prospective multicentre cohort studies are warranted to assess
the generalizability of the current ﬁndings.
The patients meeting the three predictive ﬁndings had higher
SOFA scores compared with those fulﬁlling other combinations in
the current study. It might be envisaged to interpret the reason
why these patients had higher mortality. The number of three
predictive ﬁndings present was positively associated with SOFA






9.9 5.7 < 0.001
4.03  1.30 2.77  1.95 < 0.001
14.8  5.8 9.6  1.9 < 0.001
2267.5  147.6 1163.2  129.3 < 0.001
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the degree of positive association with costs. Hospital LOS for CAP
inpatients depends on the time needed to reach clinical stability,
which is signiﬁcantly inﬂuenced by the severity of disease.16
Patients with the most severe pneumonia take the longest to
recover, remain in the hospital for longer periods, and then cost
more.
The IDSA/ATS nine minor criteria represent the functions of
different organs and organ systems. Kidney, lung and central
nervous system play pivotal physiological roles in human life,
whose dysfunctions are most strongly associated to mortality.
Therefore, the three ﬁrst predictive ﬁndings had very high OR for
mortality.
Lim et al.17 discovered the effect of employing the IDSA/ATS
minor criteria to identify severe CAP cases for early aggressive
resuscitation is undoubted. The hospital mortality rate was lower
in the intervention versus the control group (5.7% versus 23.8%,
p < 0.001). Therefore, this is the correct application of the minor
criteria. Improvement in patient management ﬁrst indeed depends
on the accuracy of ICU admission prediction. Our ﬁndings might be
important messages that would have potential to improve care of
severe CAP patients just fulﬁlling the IDSA/ATS minor criteria. They
might help us make clinical decisions about where these patients
should be treated at (ICU vs. non-ICU), and need for advance care.
Correct site-of-care can optimize initial antibiotic treatment,
because the microbial etiologies of severe CAP differ from those
associated with CAP in general.18,19 Avoidance of initial inappro-
priate antibiotic treatment is associated with lower mortality.20,21
On the basis of our ﬁndings, it might be concluded that 11.4% of
high risk patients, i.e. those fulﬁlling the three predictive ﬁndings
most strongly associated to mortality, were admitted inappropri-
ately to the general ward and might have been poorly resuscitated,
although the guideline already contemplates admission to ICU in
patients with three or more minor criteria.1 Therefore, the patients
meeting the three predictive ﬁndings most strongly associated to
mortality should have a higher priority for treatment in ICU
compared with such patients fulﬁlling other combinations of the
IDSA/ATS minor criteria, the former might beneﬁt more from ICU
admission, if there were limited ICU beds in an institution. This also
has direct clinical implications with regards to prompt recognition
and resuscitation at the emergency department which may
improve survival.
5. Limitations
Several limitations of this study deserve comment. First, this
was a two centre, not a multicentre, study. Second, although
1430 patients were assessed, the number of patients eligible for
fulﬁlling three or more IDSA/ATS minor criteria was relatively
small, so the results should be viewed with caution. Had the
number been larger, perhaps the results might have been more
robust. We did not ﬁgure out and evaluate all the possible
combinations of three or more minor criteria. It would be the best
way to come to the conclusion regarding the most accurate
combination of criteria predicting severity/mortality. Finally, the
hospital mortality in these severe CAP patients was 13.0%. Criterion
not being strongest predictive in low-mortality-rate institutions
might be very important for places where mortality is high and vice
versa. Hence, what we reported might be recalibrated to local
settings.
6. Conclusions
Different combinations of 2007 IDSA/ATS minor criteria for
severe CAP were associated to diverse severities and different
mortalities. The presence of PaO2/FiO2  250 mm Hg, confusionand uremia predicted more severity and higher mortality
compared with other combinations.
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